Shopping Cart
- Remove All
- Your shopping cart is currently empty
V1a/V2 antagonist 1 (Compound 18j) is an orally active dual-target antagonist of V1a and V2 receptors, exhibiting high binding affinity toward these receptors [Ki values are hV1a: 0.13 nM, hV2: 0.53 nM, and mV1a: 0.5 nM; IC50 for hV1a is 2.2 nM]. This compound can inhibit oxytocin-induced scratching behavior in mice.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | V1a/V2 antagonist 1 (Compound 18j) is an orally active dual-target antagonist of V1a and V2 receptors, exhibiting high binding affinity toward these receptors [Ki values are hV1a: 0.13 nM, hV2: 0.53 nM, and mV1a: 0.5 nM; IC50 for hV1a is 2.2 nM]. This compound can inhibit oxytocin-induced scratching behavior in mice. |
Targets&IC50 | V2 receptor (human):0.53 nM (Ki), V1a receptor (human):2.2 nM, V1a receptor (human):0.13 nM (Ki) |
In vitro | V1a/V2 antagonist 1 (1 μM) demonstrates excellent liver microsomal metabolic stability with Cl int (h/r/m) (μL/min/mg) values of 15.9/36.9/27.1. It exhibits no interaction with hERG (IC 50: >30 μM), and has a PDR value of 0.91 according to the VB-Caco-2 permeability assay. |
In vivo | A V1a/V2 antagonist 1, administered orally at doses of 0.1-3 mg/kg with a 60-minute pretreatment, significantly inhibits Oxytocin-induced scratching behavior in mice. |
Molecular Weight | 479.96 |
Formula | C25H26ClN5O3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.